Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling
NCT00776230
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
304
Enrollment
INDUSTRY
Sponsor class
Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL:
IC51
Sponsor
Valneva Austria GmbH